Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of department store operator J.C. Penney (NYSE: JCP ) climbed as much as 11% today on a few signs of improvement in August.
So what: Although the embattled retailer posted yet another brutal quarter -- a 22% sales plunge in the second quarter -- and even pulled its full-year guidance, confident words from CEO Ron Johnson that the restructuring remains on course is giving investors some hope. Johnson said the overhaul of its stores and a simplified pricing strategy have eased the decline in traffic in recent weeks, suggesting that the company's turnaround initiatives are at least starting to gain traction.
Now what: Although the company said it no longer expects to meet its prior profit forecast for fiscal 2012, Johnson said J.C. Penney remains well-positioned for next year. "While business continues to be softer than anticipated, we are confident the transformation of J.C. Penney is on track," said Johnson in a statement. "Our rock solid balance sheet will support the execution of our transformation and position us for growth beginning in 2013." Of course, when you couple J.C. Penney's clearly worrisome sales trends with the recent resurgence of close rival Macy's, I wouldn't exactly bet on it.
Interested in more info on J.C. Penney? Add it to your watchlist.
RSS Headlines
Fool UK
Comments from our Foolish Readers
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the
Report this Comment icon found on every comment.
Be the first one to comment on this article.